Publications by authors named "Andrew J Yee"

35Publications

Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?

JACC Cardiovasc Imaging 2020 Jun 13;13(6):1325-1336. Epub 2020 May 13.

Department of Medicine, Division of Cardiology, Cardiac Amyloidosis Program, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Department of Radiology, Division of Nuclear Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Department of Medicine and Radiology, CV Imaging Program, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcmg.2020.02.025DOI Listing
June 2020

Treatment of Smoldering Multiple Myeloma: Ready for Prime Time?

Cancers (Basel) 2020 May 13;12(5). Epub 2020 May 13.

Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12051223DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281647PMC
May 2020

How We Approach Smoldering Multiple Myeloma.

J Clin Oncol 2020 Apr 31;38(11):1119-1125. Epub 2020 Jan 31.

Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.02834DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145585PMC
April 2020

Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma.

Cancer 2019 Nov 10;125(21):3692-3698. Epub 2019 Sep 10.

Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32411DOI Listing
November 2019

Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.

N Engl J Med 2019 08;381(8):727-738

From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1903455
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1903455DOI Listing
August 2019

Value of low-dose whole-body CT in the management of patients with multiple myeloma and precursor states.

Skeletal Radiol 2019 May 14;48(5):773-779. Epub 2018 Sep 14.

Division of Musculoskeletal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Yawkey 6E, 55 Fruit Street, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00256-018-3066-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447458PMC
May 2019

Vemurafenib in Patients With Relapsed Refractory Multiple Myeloma Harboring Mutations: A Cohort of the Histology-Independent VE-BASKET Study.

JCO Precis Oncol 2018 31;2. Epub 2018 Aug 31.

and Massachusetts General Hospital, Boston, MA; and Royal Marsden Hospital, Sutton, Surrey, United Kingdom; and Memorial Sloan Kettering Cancer Center, New York; Roswell Park Cancer Institute, Buffalo, NY; and Institut Gustave Roussy, Villejuif; Centre Leon-Berard, Lyon, France; and , Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain; University Hospital Köln, Köln, Germany; and F. Hoffmann-La Roche Ltd, Basel, Switzerland; and F. Hoffmann-La Roche Ltd, Mississauga, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.18.00070DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446434PMC
August 2018

Panobinostat and Multiple Myeloma in 2018.

Oncologist 2018 05 14;23(5):516-517. Epub 2018 Feb 14.

Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0644DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947458PMC
May 2018

Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma.

J Clin Oncol 2018 03 30;36(9):859-866. Epub 2018 Jan 30.

Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.5207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905485PMC
March 2018

Denosumab for the treatment of bone disease in solid tumors and multiple myeloma.

Future Oncol 2018 Feb 20;14(3):195-203. Epub 2017 Oct 20.

Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0403DOI Listing
February 2018

Myeloma and Bone Disease.

Curr Osteoporos Rep 2017 10;15(5):483-498

Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Professional Office Building 216, 55 Fruit Street, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11914-017-0397-5DOI Listing
October 2017

Sequencing of nontransplant treatments in multiple myeloma patients with active disease.

Hematology Am Soc Hematol Educ Program 2016 Dec;2016(1):495-503

Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA; and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2016.1.495DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142445PMC
December 2016

Abdominal adipose tissue in MGUS and multiple myeloma.

Skeletal Radiol 2016 Sep 25;45(9):1277-83. Epub 2016 Jun 25.

Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Yawkey 6E, 55 Fruit Street, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00256-016-2425-4DOI Listing
September 2016

Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma.

Blood 2016 05 28;127(19):2355-6. Epub 2016 Mar 28.

Department of Medicine, Weill Medical College of Cornell University, New York, NY; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-01-694786DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003505PMC
May 2016

Progressive Onset of Extracardiac and Myocardial Symptoms: Right Heart Failure and Cor Pulmonale in a Young Man With Debilitating Polyneuropathy and Monoclonal Gammopathy.

Circulation 2015 Jul;132(1):59-67

From Divisions of Cardiology (K.N., M.Z.B., D.M.D.) and Hematology and Oncology (A.J.Y.), Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.016524DOI Listing
July 2015

Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death.

Br J Haematol 2015 May 23;169(3):423-34. Epub 2015 Feb 23.

Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13315DOI Listing
May 2015

Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapy.

Clin Cancer Res 2014 Aug 23;20(15):3955-61. Epub 2014 Jun 23.

Massachusetts General Hospital Cancer Center; Harvard Medical School, Boston, Massachusetts

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0434DOI Listing
August 2014

Advances in supportive care for multiple myeloma.

J Natl Compr Canc Netw 2014 Apr;12(4):502-11

From the aCenter for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, and bDepartment of Medicine, Indiana University School of Medicine and the Richard L. Roudebush VA Medical Center, Indianapolis, Indiana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0055DOI Listing
April 2014

Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients.

Clin Interv Aging 2012 3;7:331-8. Epub 2012 Sep 3.

Division of Hematology-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CIA.S14566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437759PMC
February 2013

CT screening for lung cancer.

N Engl J Med 2007 Feb;356(7):744-5; author reply 746-7

View Article

Download full-text PDF

Source
February 2007

Effects of coffee and napping on nighttime highway driving.

Authors:
Andrew J Yee

Ann Intern Med 2007 Feb;146(3):229; author reply 229

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-146-3-200702060-00015DOI Listing
February 2007

Successful recovery after an overdose of argatroban.

Ann Pharmacother 2006 Feb 31;40(2):336-9. Epub 2006 Jan 31.

Hematology/Oncology Unit, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114-2621, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1345/aph.1G494DOI Listing
February 2006